what is glp 1 ras GLP-1 RA Medications Discontinuation in Diabetes Care Exploring GLP-1 Receptor Agonists (GLP-1

Int J Endocrinol 2012

10.1183/16000617.0141-2022 Eur Respir Rev

The outcome no one measured (until recently) The most striking finding from the Batsis review: among 36 primary studies, none reported objective physical function outcomes

Real-world data shows persistence drops from 65% at 120 days to just 34% at 365 days

Graphical Abstract Highlights Clinical integration gap: GLP-1 receptor agonists address the metabolic roots of PCOS, yet fertility-centered pathways remain inconsistent due to limited reproductive endpoint data and periconception safety concerns

Lipase for Pancreatitis Risk While not super common, theres a small risk of pancreatitis (inflammation of the pancreas) associated with GLP-1 medications